Sought after for its strong capabilities in fund establishment, investment transactions, post-investment management, exits, liquidations, and various regulatory matters, Jincheng Tongda & Neal‘s private equity group works under the direction of Lingyan Peng, who assists clients with onshore and offshore listings, PE and venture capital investments, M&A, and more. Xin Xie offers a wide spectrum of relevant services, and Fei Ye acts for clients in litigation, as well as offering non-contentious support, such as advising on IPOs, bond issuances, and asset securitisations. Yingzhi Feng is noted for her cross-border experience, notably with PE matters involving US markets.
Legal 500 Editorial commentary
Key clients
- China Huaneng Group Co., Ltd.
- Creative Biosciences
- Wisdom SemiTeC (Suzhou) Technology Co., Ltd.
- Shanghai Chen Xianggui Catering Management Co.
- Prospect Discovery Holding Limited
- Shanghai Haihuan Technology Co., Ltd.
- Shanghai Winscene Technology Co., Ltd.
- China Jinyin Investment Limited
- ATM Capital
- Wuxi Guolian Development(Group) Co., Ltd.
- Wuxi Capital Group Co., Ltd.
- Bosing International Co. Ltd
- MoleTech
- Eastern Forest Investments, L.P.
- CDH Growth Fund III
Work highlights
Assisted Creative Biosciences with its Series C and Series D financing, IPO, and other capital operation projects.
Assisted Wisdom SemiTeC (Suzhou) Technology Co., Ltd with completing its spin-off and acquisition by a wholly-owned subsidiary of a listed company.
Practice head
Lingyan Peng
Other key lawyers
Xin Xie; Fei Ye; Yingzhi Feng